Roboligent
Roboligent is a robotics company developing AI-powered mobile manipulator robots (humanoid robots) that integrate seamlessly with human workflows in manufacturing and healthcare. They utilize advanced force-controlled soft robot technology and artificial intelligence to create safe, adaptable solutions. Their product line includes ROBIN, a soft robot with superior mobile manipulation capabilities, and REGEN, a medical device for physical therapy that aids in improving muscle strength and mobility for patients with limb disabilities. Roboligent's vision is to transform industries by automating tasks, enhancing productivity, and improving quality of life, fostering a future where humans and robots work harmoniously. They have secured significant funding, including a $1.8MM STTR Phase II contract by AFWERX.
Roboligent
Roboligent is a robotics company developing AI-powered mobile manipulator robots (humanoid robots) that integrate seamlessly with human workflows in manufacturing and healthcare. They utilize advanced force-controlled soft robot technology and artificial intelligence to create safe, adaptable solutions. Their product line includes ROBIN, a soft robot with superior mobile manipulation capabilities, and REGEN, a medical device for physical therapy that aids in improving muscle strength and mobility for patients with limb disabilities. Roboligent's vision is to transform industries by automating tasks, enhancing productivity, and improving quality of life, fostering a future where humans and robots work harmoniously. They have secured significant funding, including a $1.8MM STTR Phase II contract by AFWERX.